Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (561-570 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|July 20, 2021
Animal- versus <i>in vitro</i>-derived antibodies: avoiding the extremesAndrew R M Bradbury, Stefan Dübel, Achim Knappik, et al.
Mabs|July 6, 2021
An integrated approach for characterizing immunogenic responses toward a bispecific antibodySivan Cohen, Shan Chung, Christoph Spiess, et al.
Mabs|July 6, 2021
Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separationJack E Bramham, Stephanie A Davies, Adrian Podmore, et al.
Mabs|May 11, 2022
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variantsTatsuhiko Ozawa, Hideki Tani, Yuki Anraku, et al.
Mabs|May 11, 2022
The human antibody sequence space and structural design of the V, J regions, and CDRH3 with RosettaSamuel Schmitz, Emily A Schmitz, James E Crowe, et al.
Mabs|May 18, 2022
International nonproprietary names for monoclonal antibodies: an evolving nomenclature systemSofia S Guimaraes Koch, Robin Thorpe, Nana Kawasaki, et al.
Mabs|December 23, 2017
Integrated flow-through purification for therapeutic monoclonal antibodies processingTakamitsu Ichihara, Takao Ito, Yasuhiko Kurisu, et al.
Mabs|June 8, 2019
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunityKristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
Mabs|July 2, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPαJanet Sim, Jonathan T Sockolosky, Emma Sangalang, et al.
Mabs|June 21, 2019
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-lifeBrian C Mackness, Julie A Jaworski, Ekaterina Boudanova, et al.
Pageof 184

Showing results (561-570 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|July 20, 2021
Animal- versus <i>in vitro</i>-derived antibodies: avoiding the extremesAndrew R M Bradbury, Stefan Dübel, Achim Knappik, et al.
Mabs|July 6, 2021
An integrated approach for characterizing immunogenic responses toward a bispecific antibodySivan Cohen, Shan Chung, Christoph Spiess, et al.
Mabs|July 6, 2021
Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separationJack E Bramham, Stephanie A Davies, Adrian Podmore, et al.
Mabs|May 11, 2022
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variantsTatsuhiko Ozawa, Hideki Tani, Yuki Anraku, et al.
Mabs|May 11, 2022
The human antibody sequence space and structural design of the V, J regions, and CDRH3 with RosettaSamuel Schmitz, Emily A Schmitz, James E Crowe, et al.
Mabs|May 18, 2022
International nonproprietary names for monoclonal antibodies: an evolving nomenclature systemSofia S Guimaraes Koch, Robin Thorpe, Nana Kawasaki, et al.
Mabs|December 23, 2017
Integrated flow-through purification for therapeutic monoclonal antibodies processingTakamitsu Ichihara, Takao Ito, Yasuhiko Kurisu, et al.
Mabs|June 8, 2019
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunityKristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
Mabs|July 2, 2019
Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPαJanet Sim, Jonathan T Sockolosky, Emma Sangalang, et al.
Mabs|June 21, 2019
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-lifeBrian C Mackness, Julie A Jaworski, Ekaterina Boudanova, et al.
Pageof 184